2023. Effect of Subcutaneous Spesolimab on the Prevention of Generalized Pustular Psoriasis Flares Over 48 weeks: Subgroup Analyses from the Effisayil 2 Trial . SKIN The Journal of Cutaneous Medicine. 7, 6 (Nov. 2023), s245. DOI:https://doi.org/10.25251/skin.7.supp.245.